- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Conexeu Sciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| CONEXEU SCIENCES Aktie jetzt für 0€ handeln | |||||
| 08.06. | Conexeu Sciences: Aktie legt nach Fortschritten bei Wundversorgungs-Produkt zu | 1 | Investing.com Deutsch | ||
| 08.06. | Conexeu forciert Produktionsaufbau für Wundpflege-Produkt vor geplantem FDA-Antrag 2027 | - | Investing.com Deutsch | ||
| 08.06. | Conexeu Sciences Inc.: Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU Wound Care Program | 1 | GlobeNewswire (USA) | ||
| 03.06. | Conexeu Sciences Inc.: Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 | 1 | GlobeNewswire (USA) | ||
| 21.05. | Conexeu Sciences Inc.: Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU" | 447 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially... ► Artikel lesen | |
| 19.05. | Conexeu Sciences Inc.: Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants | 425 | Newsfile | Conexeu's B.R.E.A.S.T. was developed using the Company's proprietary CXU regenerative tissue platform to support gradual tissue remodelingDesigned as a resorbable, bioregenerative tissue matrix... ► Artikel lesen | |
| 14.05. | Conexeu Sciences Inc.: Conexeu Sciences Unveils Defining Commitment: Architecting Bioregeneration | 417 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 14, 2026) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a medical device company advancing regenerative medicine through its patented bioregenerative extracellular... ► Artikel lesen | |
| 12.05. | Medical device developer Conexeu Sciences set to direct list on the Nasdaq on May 21 | 1 | Renaissance Capital | ||
| 11.05. | Conexeu Sciences Inc. - 8-A12B, Registration of securities | - | SEC Filings | ||
| 17.04. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 06.04. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 26.03. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 02.03. | Conexeu Sciences Inc.: Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing | 802 | Newsfile | Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular... ► Artikel lesen | |
| 09.02. | Conexeu Sciences Inc.: Conexeu Sciences Appoints Sonia Thomas as Head of Strategy & Transformation to Accelerate Enterprise Growth and Execution Excellence | 971 | Newsfile | Reno, Nevada--(Newsfile Corp. - February 9, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company") a biotechnology innovator redefining regenerative medicine through a next-generation extracellular... ► Artikel lesen | |
| 03.02. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 20.11.25 | Conexeu Sciences Inc.: Conexeu Sciences Signals a Major Breakthrough in 'Personalized Human Tissue Creation' | 241 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 20, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based... ► Artikel lesen | |
| 05.11.25 | Conexeu Sciences Inc. Expands Board of Directors with the Appointments of Dr. Aaron Farberg and Dr. Sebastian Purcell | 254 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 5, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based... ► Artikel lesen | |
| 03.11.25 | Conexeu Sciences Inc.: Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration | 262 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 3, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation... ► Artikel lesen | |
| 16.10.25 | Conexeu Sciences Inc.: Conexeu Sciences Closes Maximum $5M Reg CF Financing | 450 | Newsfile | Reno, Nevada--(Newsfile Corp. - October 16, 2025) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a biotechnology company revolutionizing tissue regeneration, is pleased to announce the completion... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 63,23 | 0,00 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| CUPRINA HOLDINGS | 3,940 | -0,76 % | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,765 | +0,08 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| GENEDX | 59,92 | 0,00 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| FRESENIUS | 38,600 | +3,62 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
04.06.2026 /... ► Artikel lesen | |
| HEARTFLOW | 33,210 | -0,09 % | Piper Sandler bestätigt Rating für Heartflow: Plaque-Umsätze sollen Wachstum antreiben | ||
| BILLIONTOONE | 101,02 | -0,10 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,580 | +4,86 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 37 Euro auf "Sell" belassen. Theranova bleibe nach einer Präsentation auf der Konferenz der European... ► Artikel lesen | |
| PROGYNY | 26,650 | +0,08 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| PROCEPT BIOROBOTICS | 25,705 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| AVEANNA HEALTHCARE | 7,090 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,240 | +2,44 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 8,495 | -0,06 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,440 | +0,04 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,900 | +0,51 % | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control | - Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining... ► Artikel lesen |
Das Unternehmen CONEXEU SCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,210 (+1,86 %) liegt der Kurs bei 11,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CONEXEU SCIENCES INC finden Sie auf Wallstreet Online.